Eupraxia Pharmaceuticals Inc.
EPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001581178
No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Eupraxia Pharmaceuticals Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +9 vs. Q3 2025
- Shares held
- 13.9M
- +1.14M (+8.9%) vs. Q3 2025
- Total value
- $105.1M
- +$29.8M (+39.6%) vs. Q3 2025
- New holders
- 15
- 8 more added
- Sold out
- 6
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 67 | $163.6M |
| Q1 2026 | 55 | $160.3M |
| Q4 2025 | 36 | $105.1M |
| Q3 2025 | 27 | $75.3M |
| Q2 2025 | 14 | $10.9M |
| Q1 2025 | 11 | $7.09M |
| Q4 2024 | 9 | $5.63M |
| Q3 2024 | 8 | $4.55M |
| Q2 2024 | 8 | $4.43M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Eupraxia Pharmaceuticals Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| National Bank of Canada | 586 | $4.44K | 0.00% | −296−33.6% | Reduced |
| Federation des caisses Desjardins du Quebec | 9,091 | $67.9K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 9,600 | $71.7K | 0.00% | 00.0% | Unchanged |
| Aptus Capital Advisors, LLC | 10,000 | $75.5K | 0.00% | +10,000 | New |
| Guardian Wealth Advisors, LLC | 10,000 | $75.5K | 0.00% | +10,000 | New |
| TCI Wealth Advisors, Inc. | 11,000 | $83.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 13,899 | $104.9K | 0.00% | +13,899 | New |
| XTX Topco Ltd | 16,180 | $122.2K | 0.00% | +16,180 | New |
| Jane Street Group, LLC | 29,622 | $222.8K | 0.00% | +29,622 | New |
| 1832 Asset Management L.P. | 32,138 | $242.6K | 0.00% | +32,138 | New |
| Bank of Montreal | 37,250 | $280.1K | 0.00% | 00.0% | Unchanged |
| Quadrature Capital Ltd | 43,186 | $325.6K | 0.00% | +43,186 | New |
| Raymond James Financial Inc | 52,972 | $399.9K | 0.00% | +19,599+58.7% | Added |
| CIBC World Markets Inc. | 58,050 | $436.5K | 0.00% | +43,050+287.0% | Added |
| Goldman Sachs Group Inc | 58,058 | $438.3K | 0.00% | +17,958+44.8% | Added |
| Ingalls & Snyder LLC | 77,400 | $584.0K | 0.02% | +18,300+31.0% | Added |
| Delaney Capital Management Ltd. | 119,400 | $899.0K | 0.15% | +119,400 | New |
| Acadian Asset Management LLC | 155,766 | $1.17M | 0.00% | +134,366+627.9% | Added |
| Boothbay Fund Management, LLC | 156,331 | $1.18M | 0.03% | +156,331 | New |
| Marshall Wace, LLP | 158,133 | $1.19M | 0.00% | +158,133 | New |
| SummitTX Capital, L.P. | 175,948 | $1.33M | 0.04% | +175,948 | New |
| Royal Bank of Canada | 196,277 | $1.48M | 0.00% | −232,527−54.2% | Reduced |
| UBS Group AG | 220,024 | $1.66M | 0.00% | +124,268+129.8% | Added |
| Bank of America Corp | 253,321 | $1.91M | 0.00% | +207,744+455.8% | Added |
| Arrowstreet Capital, Limited Partnership | 278,064 | $2.09M | 0.00% | +278,064 | New |
| Affinity Asset Advisors, LLC | 300,000 | $2.27M | 0.16% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 352,000 | $2.66M | 1.55% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 397,895 | $3.00M | 4.77% | −517,105−56.5% | Reduced |
| Squadron Capital Management LLC | 500,000 | $3.77M | 1.68% | +500,000 | New |
| Ikarian Capital, LLC | 610,000 | $4.61M | 0.60% | +610,000 | New |
| Point72 Asset Management, L.P. | 712,104 | $5.38M | 0.01% | +712,104 | New |
| Great Point Partners LLC | 1,200,000 | $9.06M | 2.94% | 00.0% | Unchanged |
| Scotia Capital Inc. | 1,286,183 | $9.60M | 0.04% | +8,298+0.6% | Added |
| Balyasny Asset Management LLC | 1,350,000 | $10.2M | 0.02% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,350,000 | $10.2M | 0.66% | 00.0% | Unchanged |
| Beutel, Goodman & Co Ltd. | 3,709,373 | $27.9M | 0.17% | −349,526−8.6% | Reduced |
| Logos Global Management LP | 0 | $0 | 0.00% | −900,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Guardian Partners Inc. | 0 | $0 | 0.00% | −24,130−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −16,467−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −9−100.0% | Sold out |